Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support ...

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

- Plan to meet with the FDA in the second half of 2025 to discuss potential registrational pathways for both monotherapy and combination therapy for WTX-124 in select indications - - Interim data from ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...

Nicola Sturgeon to stand down from Holyrood next year EPA likely to move to further limit federal protections for wetlands RFK Jr. says bird flu vaccines could turn ‘flocks into mutation ...

Aims: To describe the clinical features and outcomes of PSC-IBD and compare these to a group of chronic ulcerative colitis (CUC) patients. Methods: The medical records of all patients with PSC-IBD ...

This advertisement has not loaded yet, but your article continues below.

This advertisement has not loaded yet, but your article continues below.

This advertisement has not loaded yet, but your article continues below.

International conclave on IBD held by Yashoda Hospital More than 300 gastroenterologists and surgeons from India, Singapore, United States and other countries, participated in an international ...